Hennion & Walsh Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,591
Closed -$314K 978
2025
Q4
$314K Sell
12,591
-1,440
-10% -$36.3K 0.01% 824
2025
Q3
$358K Sell
14,031
-13,320
-49% -$329K 0.01% 794
2025
Q2
$663K Sell
27,351
-1,791
-6% -$41.8K 0.03% 591
2025
Q1
$738K Sell
29,142
-7,192
-20% -$188K 0.03% 546
2024
Q4
$964K Sell
36,334
-3,253
-8% -$88.2K 0.04% 472
2024
Q3
$1.15M Sell
39,587
-5,256
-12% -$153K 0.05% 418
2024
Q2
$1.25M Buy
44,843
+3,568
+9% +$98.2K 0.06% 372
2024
Q1
$1.15M Buy
41,275
+5,682
+16% +$158K 0.06% 391
2023
Q4
$1.02M Buy
35,593
+2,360
+7% +$71.3K 0.06% 402
2023
Q3
$1.1M Buy
33,233
+9,223
+38% +$326K 0.07% 336
2023
Q2
$881K Buy
24,010
+3,707
+18% +$144K 0.05% 395
2023
Q1
$828K Sell
20,303
-5,223
-20% -$226K 0.05% 400
2022
Q4
$1.31M Sell
25,526
-221
-0.9% -$10.6K 0.08% 285
2022
Q3
$1.13M Sell
25,747
-30,214
-54% -$1.47M 0.07% 294
2022
Q2
$2.93M Sell
55,961
-6,233
-10% -$318K 0.18% 145
2022
Q1
$3.22M Sell
62,194
-1,620
-3% -$84.1K 0.17% 161
2021
Q4
$3.77M Sell
63,814
-10,751
-14% -$533K 0.19% 149
2021
Q3
$3.21M Sell
74,565
-21,363
-22% -$946K 0.17% 176
2021
Q2
$3.76M Sell
95,928
-12,613
-12% -$490K 0.2% 131
2021
Q1
$3.93M Buy
+108,541
New +$3.85M 0.24% 111

Other funds holding PFE

Hennion & Walsh Asset Management's PFE Position: Q1 2026 in Review

Hennion & Walsh Asset Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 12,591 shares — an estimated $314K sold.

Hennion & Walsh Asset Management first reported a position in PFE in Q1 2021 and held it in 20 quarters. The position peaked at $3.93M in Q1 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Hennion & Walsh Asset Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 12,591 Pfizer shares in Q1 2026, an estimated $314K.
  • Hennion & Walsh Asset Management first reported a position in Pfizer in Q1 2021 and held it in 20 quarters.
  • Hennion & Walsh Asset Management's Pfizer position peaked at $3.93M in Q1 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q1 2026, filed 13 May 2026.